Search

everythinglearnresearchcommunity

for

Search:↓

Spironolactone may help reduce hair loss in androgenic alopecia.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

Obstetrician/gynecologists can diagnose and manage female hair loss with careful history taking and examination.

Immune cells affect hair growth and could lead to new hair loss treatments.

MILL molecules are unique immune proteins in mice that don't need TAP to appear on cell surfaces.

Recent genetic insights show that low-renin hypertension includes a range from essential hypertension to secondary or familial forms, affecting diagnosis and treatment.

New treatments for PCOS focus on managing symptoms and improving fertility.

Skin problems like excessive hair growth, acne, and dark skin patches can be signs of Polycystic Ovarian Disease, which may also be linked to family history and a risk for diabetes.

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

Hair loss can be treated with medications like minoxidil and finasteride or surgery, but treatment effectiveness varies by alopecia type and accurate diagnosis is important.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

The link between physical signs of high male hormones and hormone levels in women with PCOS changes with age.

An over-the-counter vitamin/mineral supplement improved hair loss and blood sugar control in a woman with non-classic 11-hydroxylase deficiency.

Acne in children varies by age and severity, requires a pediatric treatment approach, and may need diagnostic evaluation for underlying conditions.

Female hair loss patients more likely to have dry eye and gland issues.

Measuring the distance from the anus to the clitoris may moderately help diagnose polycystic ovary syndrome, especially in certain cases.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

Acne and hair loss are not good indicators of hormone imbalance in PCOS, but excessive body hair is.

Hirsutism is a strong sign of high male hormones and metabolic problems in women with PCOS, but acne and hair loss are not.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Hair relaxers are linked to reduced cystine levels and potential hair damage.

The document suggests that there might be an autoimmune link between polycystic ovary syndrome and Graves' disease.

Polycystic Ovary Syndrome (PCOS) is common in infertile women and obese women with PCOS have more severe ovulatory problems, needing more care.

Obesity increases the risk of developing polycystic ovary syndrome, and weight loss can improve the condition.

Certain gene variants in estrogen receptors are linked to polycystic ovary syndrome, mainly affecting metabolism, in Tunisian women.

Many patients experienced hair loss after COVID-19, with women affected more, starting on average 49 days post-infection.

PCOS is a common hormonal disorder in women that can lead to serious health problems.

A condition with certain scalp changes may come before acne keloidalis nuchae and other similar hair loss disorders.